Symic Biomedical's Series B Round

Symic Biomedical raised a round of funding on May 22, 2017.

Symic Bio is a biopharmaceutical company developing a new category of therapeutics focused on matrix biology. The Symic Bio platform of matrix-targeting biotherapeutics builds upon emerging research o…

Articles about Symic Biomedical's Series B Round: